TP53-Mutant CHIP Marks a High-Risk CAR-T Phenotype

Institution: LMU University Hospital Munich · Finding: TP53-Mutant Clonal Hematopoiesis (CHIP) · Context: Commercial CD19/BCMA CAR-T Recipients · Study Type: Peer-Reviewed, Single-Center, Retrospective · Date: September 2, 2026 Summary A peer-reviewed, single-center study of 104 recipients of commercial CD19- or BCMA-directed CAR-T therapy found that…